Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03595657
Title A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors CStone Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Peking University Third Hospital Beijing China Details
Hunan Cancer Hospital Changsha China Details
West China Hospital of Sichuan University Chengdu China Details
Fujian Cancer Hospital Fuzhou China Details
Sun Yat-sen University Cancer Prevention Center Guangzhou China Details
Guizhou Cancer Hospital Guiyang China Details
The First Affiliated Hospital of Zhejiang University Hangzhou China Details
Zhejiang Cancer Hospital Hangzhou China Details
Anhui Cancer Hospital Hefei China Details
Cancer Hospital Affiliated to Guangxi Medical University Nanning China Details
Fudan University Shanghai Cancer Hospital Shanghai China Details
Shanghai East Hospital Shanghai China Details
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China Details
Liaoning Cancer Hospital Shenyang China Details
Tianjin Cancer Hospital Tianjin China Details
Cancer Center of Union Hospital, Huazhong University of Science and Technology Wuhan China Details
Henan Cancer Hospital Zhengzhou China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field